With the analysis among 167 patents, we discovered top 17 key players by total patent application. Genentech, Inc., Regeneron Pharmaceuticals, Inc., ImClone LLC are dominant in this area. They take 64.67% of the total patent filing.
California, United States
Patent: 64
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 22
New York, United States
Patent: 22
Bristol-Myers Squibb FCT bêta, Inc.
F. Hoffmann-La Roche Ltd.
Texas, United States
Patent: 5
Indiana, United States
Patent: 4
London Health Sciences Centre Research, Inc.
Birdie Biopharmaceuticals Inc
No data, please try another search term
With the analysis among related 19 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Korea Research Institute of Chemical Technology, Bristol-Myers Squibb FCT bêta, Inc., Regeneron Pharmaceuticals, Inc. take 73.68% of patent filing during this period.
Korea Research Institute of Chemical Technology
Bristol-Myers Squibb FCT bêta, Inc.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 2
California, United States
Patent: 2
Shenzhen Institute of Advanced Technology
undefined undefined
Patent: 1
Birdie Biopharmaceuticals Inc
Beijing Yunhui Pharmaceutical Technology Co., Ltd.
Beijing Shi, China
Patent: 1
With the analysis among related 19 patents in last 5 years, we discover 3 new entrants.
Korea Research Institute of Chemical Technology
Shenzhen Institute of Advanced Technology
undefined undefined
Patent: 1
Beijing Yunhui Pharmaceutical Technology Co., Ltd.
Beijing Shi, China
Patent: 1
With the analysis among 31 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Institut Gustave Roussy EURL
The University of Queensland
Queensland, Australia
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1